IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Community shaken after student killed in shooting at Texas high school

    01:44
  • U.S. aid worker and French journalist freed after being held hostage for years

    01:24
  • Immediate action needed to address global warming, according to new U.N. report

    02:27
  • Meet the Press NOW — March 20

    49:49
  • New report proves disparities in PTSD care for Black veterans

    05:22
  • War crimes warrant for Putin could push Russia, China together

    05:15
  • Full Panel: Trump’s call for protests has an ‘eerie echo’ to Jan. 6th

    08:01
  • Grand jury in Trump investigation suggests DA seeks felony charge

    15:37
  • Student killed in Texas school shooting, suspect in custody

    02:06
  • Navajo Nation argues water rights case before Supreme Court

    01:14
  • French President Macron survives first vote of no confidence

    02:18
  • 'Ted Lasso' cast discusses mental health at White House briefing

    02:10
  • How one organization is allowing disabled skiers to hit the slopes

    02:19
  • Amazon CEO says company will cut 9,000 jobs

    00:42
  • Two wounded in shooting at Texas high school, suspect in custody

    01:33
  • NYC’s Museum of Chinese in America set to reopen in 2025 after fire

    04:06
  • Three men found guilty in murder of rapper XXXTentacion

    02:40
  • Protesters and supporters face off at NYC Drag Story Hour

    01:15
  • Russia welcomes China’s ‘proposals for resolving’ war in Ukraine, Putin says

    01:32
  • Protesters block French highway, garbage depot over pension reforms

    01:12

Dr: New MS drug a ‘big step in the right direction’

02:35

Dr. Robert Fox, a neurologist at the Cleveland Clinic who headed the BG-12 study, says the drug is not a cure for MS, but it is well tolerated and helps decrease new lesions.